eligibility for clinicaltrials:NCT00049660 [clinicaltrials_resource:afb638c3561270047cf757f97481c37a]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT00049660 [clinicaltrials_resource:afb638c3561270047cf757f97481c37a]
Bio2RDF identifier
afb638c3561270047cf757f97481c37a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:afb638c3561270047cf757f97481c37a
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
DISEASE CHARACTERISTICS:
...... nt brivudine with capecitabine
identifier
clinicaltrials_resource:afb638c3561270047cf757f97481c37a
title
eligibility for clinicaltrials:NCT00049660
@en
type
label
eligibility for clinicaltrials ...... 638c3561270047cf757f97481c37a]
@en